Apyx Medical Stock Current Valuation
| APYX Stock | USD 1.26 0.10 8.62% |
Valuation analysis of Apyx Medical helps investors to measure Apyx Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -1.83 in 2025. Enterprise Value Multiple is likely to drop to -1.83 in 2025. Fundamental drivers impacting Apyx Medical's valuation include:
Overvalued
Today
Please note that Apyx Medical's price fluctuation is extremely dangerous at this time. Calculation of the real value of Apyx Medical is based on 3 months time horizon. Increasing Apyx Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Apyx Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Apyx Stock. However, Apyx Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.26 | Real 1.07 | Target 3.0 | Hype 1.26 | Naive 1.38 |
The intrinsic value of Apyx Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Apyx Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Apyx Medical helps investors to forecast how Apyx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Apyx Medical more accurately as focusing exclusively on Apyx Medical's fundamentals will not take into account other important factors: Apyx Medical Company Current Valuation Analysis
Apyx Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Apyx Medical Current Valuation | 53.89 M |
Most of Apyx Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Apyx Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Apyx Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Apyx Medical is extremely important. It helps to project a fair market value of Apyx Stock properly, considering its historical fundamentals such as Current Valuation. Since Apyx Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Apyx Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Apyx Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Apyx Current Valuation Historical Pattern
Today, most investors in Apyx Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Apyx Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Apyx Medical current valuation as a starting point in their analysis.
Apyx Medical Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Apyx Medical has a Current Valuation of 53.89 M. This is 99.62% lower than that of the Health Care Equipment & Supplies sector and 99.57% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.68% higher than that of the company.
Apyx Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Apyx Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Apyx Medical could also be used in its relative valuation, which is a method of valuing Apyx Medical by comparing valuation metrics of similar companies.Apyx Medical is currently under evaluation in current valuation category among its peers.
Apyx Fundamentals
| Return On Equity | -1.14 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.49) % | ||||
| Operating Margin | (0.21) % | ||||
| Current Valuation | 53.89 M | ||||
| Shares Outstanding | 37.79 M | ||||
| Shares Owned By Insiders | 14.55 % | ||||
| Shares Owned By Institutions | 45.84 % | ||||
| Number Of Shares Shorted | 141.85 K | ||||
| Price To Earning | 4.04 X | ||||
| Price To Book | 3.30 X | ||||
| Price To Sales | 0.99 X | ||||
| Revenue | 48.1 M | ||||
| Gross Profit | 29.36 M | ||||
| EBITDA | (16.8 M) | ||||
| Net Income | (23.56 M) | ||||
| Cash And Equivalents | 20.06 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 4.87 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 4.45 X | ||||
| Book Value Per Share | 0.38 X | ||||
| Cash Flow From Operations | (18.05 M) | ||||
| Short Ratio | 6.21 X | ||||
| Earnings Per Share | (0.66) X | ||||
| Price To Earnings To Growth | (0.58) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 220 | ||||
| Beta | 1.18 | ||||
| Market Capitalization | 47.62 M | ||||
| Total Asset | 64.84 M | ||||
| Retained Earnings | (77.91 M) | ||||
| Working Capital | 45.72 M | ||||
| Current Asset | 10.01 M | ||||
| Current Liabilities | 2.45 M | ||||
| Net Asset | 64.84 M |
About Apyx Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apyx Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apyx Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apyx Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Apyx Stock Analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.